Diabetic Nephropathies

• 

  Subject Areas on Research

  • A 55-year-old man with fever, renal failure, and hip pain. 
  • A Comprehensive Cardiovascular-Renal-Metabolic Risk Reduction Approach to Patients with Type 2 Diabetes Mellitus. 
  • A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group. 
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 
  • A randomized trial of a 6-week course of celecoxib on proteinuria in diabetic kidney disease. 
  • Analysis of clinical predictors of kidney diseases in type 2 diabetes patients based on machine learning. 
  • Analysis of early readmissions after combined pancreas-kidney transplantation. 
  • Angiotensin converting enzyme 2 and the kidney. 
  • Appearance of immune complex glomerulonephritis following the onset of type I diabetes mellitus in a child. 
  • Are low-carbohydrate diets safe in diabetic and nondiabetic chronic kidney disease? 
  • Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population. 
  • Association of high pulse pressure with proteinuria in subjects with diabetes, prediabetes, or normal glucose tolerance in a large Japanese general population sample. 
  • Associations between complications and health-related quality of life in individuals with diabetes. 
  • Augmenting podocyte injury promotes advanced diabetic kidney disease in Akita mice. 
  • Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. 
  • CKD progression and mortality among older patients with diabetes. 
  • Candida fasciitis following renal transplantation. 
  • Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). 
  • Cardiovascular complications of diabetic kidney disease. 
  • Clinical Fractures Among Older Men With Diabetes Are Mediated by Diabetic Complications. 
  • Clinical experience with human anodal trypsinogen (HAT) for detection of pancreatic allograft rejection. 
  • Competing Risk of Death With End-Stage Renal Disease in Diabetic Kidney Disease. 
  • Compounds targeting OSBPL7 increase ABCA1-dependent cholesterol efflux preserving kidney function in two models of kidney disease. 
  • Control of blood pressure in chronic kidney disease: how low to go? 
  • Declining influence of race on the outcome of living-donor renal transplantation. 
  • Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations? 
  • Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE). 
  • Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial. 
  • Diabetes mellitus, independent of body mass index, is associated with a "higher success" rate for supraclavicular brachial plexus blocks. 
  • Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion. 
  • Diabetic kidney disease: a report from an ADA Consensus Conference. 
  • Diabetic kidney disease: a report from an ADA Consensus Conference. 
  • Diabetic nephropathy: a national dialogue. 
  • Diabetic nephropathy: of mice and men. 
  • Dialysis or transplantation: fitting the treatment to the patient. 
  • Dual RAAS blockade for kidney failure: hope for the future. 
  • Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis. 
  • Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. 
  • Effects of Selonsertib in Patients with Diabetic Kidney Disease. 
  • FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. 
  • Fibroblast growth factor 23 and incident CKD in type 2 diabetes. 
  • Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO-DKD trial. 
  • Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. 
  • Frequency of hypoglycemia and its significance in chronic kidney disease. 
  • Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes. 
  • Gq signaling causes glomerular injury by activating TRPC6. 
  • Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. 
  • High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study. 
  • ISPAD Clinical Practice Consensus Guidelines 2014. Microvascular and macrovascular complications in children and adolescents. 
  • Identification of a protective proteomic signature and a potential therapeutic target in diabetic nephropathy. 
  • Impact of genetic background on nephropathy in diabetic mice. 
  • Incidence and Progression of Chronic Kidney Disease in Black and White Individuals with Type 2 Diabetes. 
  • Inflammation and Immunity Pathways Regulate Genetic Susceptibility to Diabetic Nephropathy. 
  • Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice. 
  • Is chronic kidney disease associated with diabetic retinopathy in Asian adults? 
  • Is there a clear threshold for fasting plasma glucose that differentiates between those with and without neuropathy and chronic kidney disease?: the Singapore Prospective Study Program. 
  • Is there a transfusion effect in combined pancreas-kidney transplantation? 
  • JCL Roundtable. Obesity, Diabetes, and Liver Disease in Relation to Cardiovascular Risk. 
  • Knockout of TRPC6 promotes insulin resistance and exacerbates glomerular injury in Akita mice. 
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? 
  • Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General Population. 
  • Losartan potassium (Cozaar). 
  • Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference. 
  • Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Microarray analysis of multiple candidate genes and associated plasma proteins for nephropathy secondary to type 2 diabetes among Chinese individuals. 
  • Modelling diabetic nephropathy in mice. 
  • Mouse models of diabetic nephropathy. 
  • Mouse models of diabetic nephropathy. 
  • Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage. 
  • Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association. 
  • Pancreas transplantation: the Nebraska experience. 
  • Performance of Indexed and Nonindexed Estimated GFR. 
  • Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease. 
  • Preventing renal dysfunction in patients with hypertension: clinical implications from the early AASK Trial results. 
  • Primary Care Providers' Acceptance of Pharmacists' Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease. 
  • Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease. 
  • Racial differences in nocturnal dipping status in diabetic kidney disease: Results from the STOP-DKD (Simultaneous Risk Factor Control Using Telehealth to Slow Progression of Diabetic Kidney Disease) study. 
  • Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. 
  • Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. 
  • Relation between BMI and diabetes mellitus and its complications among US older adults. 
  • Relationship between glycated haemoglobin and microvascular complications: is there a natural cut-off point for the diagnosis of diabetes? 
  • Renal Disease Risk Factors Among Risk Groups Comprised of African American Women With Type 2 Diabetes: A Secondary Analysis. 
  • Renal Interstitial Fibrosis: An Imperfect Predictor of Kidney Disease Progression in Some Patient Cohorts. 
  • Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. The Collaborative Study Group. 
  • Research Priorities for Kidney-Related Research-An Agenda to Advance Kidney Care: A Position Statement From the National Kidney Foundation. 
  • Retinal arteriolar tortuosity is associated with retinopathy and early kidney dysfunction in type 1 diabetes. 
  • Retinal vascular caliber as a biomarker for diabetes microvascular complications. 
  • Retinal vessel caliber and microvascular and macrovascular disease in type 2 diabetes: XXI: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. 
  • Retinal vessel calibers predict long-term microvascular complications in type 1 diabetes: the Danish Cohort of Pediatric Diabetes 1987 (DCPD1987). 
  • Retinal vessel diameters and the incidence of gross proteinuria and renal insufficiency in people with type 1 diabetes. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Risk factors for lower extremity amputation among patients with diabetes in Singapore. 
  • Role of Acid-Base Homeostasis in Diabetic Kidney Disease. 
  • Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications. 
  • Ruboxistaurin. 
  • SMPDL3b modulates insulin receptor signaling in diabetic kidney disease. 
  • Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial. 
  • Simultaneous kidney-pancreas transplantation at the University of Wisconsin. 
  • Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. 
  • Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. 
  • Strategies for preventing diabetic nephropathy. 
  • Stressed-out podocytes in diabetes? 
  • TRENDS IN THE CARE AND OUTCOMES OF MEDICARE BENEFICIARIES WITH TYPE 2 DIABETES, 2002-2011. 
  • TRPC Channels in Proteinuric Kidney Diseases. 
  • Targeting VE-PTP phosphatase protects the kidney from diabetic injury. 
  • The Relationship of Quantitative Retinal Capillary Network to Kidney Function in Type 2 Diabetes. 
  • The renin-angiotensin system and diabetic nephropathy. 
  • Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link? 
  • Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study. 
  • Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients. 
  • Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy. 
  • Urine tricarboxylic acid cycle signatures of early-stage diabetic kidney disease. 
  • Wnt/β-catenin pathway in podocytes integrates cell adhesion, differentiation, and survival.